Clinical Trial for the Treatment of Refractory Ascites Secondary to Decompensated Liver Cirrhosis

Clinical Trial Title

Safety and Efficacy of an Investigational Drug, in Addition to Standard of Care, Compared to Standard of Care to Reduce the Recurrence of Ascites and Complications in Patients with Refractory Ascites Secondary to Decompensated Liver Cirrhosis

National Clinical Trial Number:


Contact Information

Clinical Trial Protocol Description:

This is a study investigating whether or not a particular drug is helpful in treating reoccurring ascites in patients with advanced liver disease.

Clinical Trial Eligibility Criteria:

In order to participate you must meet the following criteria:

  • Have diuretic-resistant ascites or intractable ascites.
  • Have required frequent parenthesis within the past 60 days.

You will be excluded from the study if any of the following criteria apply to you:

  • Have a total bilirubin >5.
  • Have total platelets between 65,000-100,000.

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Study Details

Clinical Trial Investigator

Sujit Janardhan

Contact Information

Diana Goldman

Clinical Trial Location

Rush University Medical Center


Rush University Medical Center

1620 W Harrison St
Chicago, IL 60612

Get Directions

Clinical Trial FAQs

Find out if a clinical trial makes sense for you.

Learn more
Learn more